Agilent Technologies Inc (NYSE:A) Director Heidi Fields sold 5,482 shares of the firm’s stock in a transaction dated Tuesday, September 11th. The shares were sold at an average price of $67.73, for a total transaction of $371,295.86. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link.

Shares of Agilent Technologies stock opened at $68.85 on Friday. The company has a market cap of $21.65 billion, a P/E ratio of 25.63, a P/E/G ratio of 2.33 and a beta of 1.35. The company has a debt-to-equity ratio of 0.39, a quick ratio of 3.00 and a current ratio of 3.62. Agilent Technologies Inc has a 1 year low of $60.42 and a 1 year high of $75.00.

Agilent Technologies (NYSE:A) last announced its quarterly earnings results on Tuesday, August 14th. The medical research company reported $0.67 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.63 by $0.04. The company had revenue of $1.20 billion for the quarter, compared to analyst estimates of $1.20 billion. Agilent Technologies had a net margin of 6.20% and a return on equity of 18.61%. The firm’s revenue was up 8.0% on a year-over-year basis. During the same period in the previous year, the firm posted $0.59 EPS. equities research analysts forecast that Agilent Technologies Inc will post 2.71 EPS for the current year.

Institutional investors have recently made changes to their positions in the stock. BlackRock Inc. grew its holdings in Agilent Technologies by 10.8% during the 1st quarter. BlackRock Inc. now owns 28,445,160 shares of the medical research company’s stock worth $1,902,983,000 after acquiring an additional 2,779,802 shares during the last quarter. OppenheimerFunds Inc. grew its holdings in Agilent Technologies by 64.0% during the 2nd quarter. OppenheimerFunds Inc. now owns 7,636,621 shares of the medical research company’s stock worth $472,248,000 after acquiring an additional 2,980,216 shares during the last quarter. American Century Companies Inc. grew its holdings in Agilent Technologies by 30.3% during the 2nd quarter. American Century Companies Inc. now owns 4,585,162 shares of the medical research company’s stock worth $283,546,000 after acquiring an additional 1,065,877 shares during the last quarter. Wells Fargo & Company MN grew its holdings in Agilent Technologies by 6.6% during the 2nd quarter. Wells Fargo & Company MN now owns 2,984,214 shares of the medical research company’s stock worth $184,544,000 after acquiring an additional 183,728 shares during the last quarter. Finally, Old Mutual Global Investors UK Ltd. bought a new stake in Agilent Technologies during the 1st quarter worth approximately $100,067,000.

Several equities analysts have commented on the stock. ValuEngine raised shares of Agilent Technologies from a “hold” rating to a “buy” rating in a report on Thursday. Zacks Investment Research raised shares of Agilent Technologies from a “hold” rating to a “buy” rating and set a $74.00 price target on the stock in a report on Tuesday, August 7th. Morgan Stanley lifted their price target on shares of Agilent Technologies from $83.00 to $84.00 and gave the company an “overweight” rating in a report on Wednesday, August 15th. Finally, Deutsche Bank lifted their price target on shares of Agilent Technologies from $77.00 to $80.00 and gave the company a “buy” rating in a report on Wednesday, August 15th. Ten research analysts have rated the stock with a buy rating, The company has a consensus rating of “Buy” and an average target price of $75.67.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. It operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; microfluidics based automated electrophoresis products; cell analysis plate based assays; laboratory software and informatics systems; laboratory automation; dissolution testing; vacuum pumps; and measurement technologies.

Recommended Story: Compound Annual Growth Rate (CAGR)

Insider Buying and Selling by Quarter for Agilent Technologies (NYSE:A)

Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.